Acquisition of MyoKardia by Bristol-Myers Squibb

Bristol-Myers Squibb acquired MyoKardia for $13.1 billion.

Is a

Acquired Company

Acquirer

Acquisition Amount (USD)

13,100,000,000

Date Announced

October 5, 2020

Transaction Date Closed

November 17, 2020

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like Acquisition of MyoKardia by Bristol-Myers Squibb

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.